Search

Your search keyword '"Obeid, Elias"' showing total 85 results
Start Over "Obeid, Elias"
85 results on '"Obeid, Elias"'

52. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers

Author

Guindalini, Rodrigo Santa Cruz, primary, Zheng, Yonglan, additional, Abe, Hiroyuki, additional, Whitaker, Kristen, additional, Yoshimatsu, Toshio F., additional, Walsh, Tom, additional, Schacht, David, additional, Kulkarni, Kirti, additional, Sheth, Deepa, additional, Verp, Marion S., additional, Bradbury, Angela R., additional, Churpek, Jane, additional, Obeid, Elias, additional, Mueller, Jeffrey, additional, Khramtsova, Galina, additional, Liu, Fang, additional, Raoul, Akila, additional, Cao, Hongyuan, additional, Romero, Iris L., additional, Hong, Susan, additional, Livingston, Robert, additional, Jaskowiak, Nora, additional, Wang, Xiaoming, additional, Debiasi, Marcio, additional, Pritchard, Colin C., additional, King, Mary-Claire, additional, Karczmar, Gregory, additional, Newstead, Gillian M., additional, Huo, Dezheng, additional, and Olopade, Olufunmilayo I., additional

Published
2019
Full Text
View/download PDF

53. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Author

Mikropoulos, Christos, Selkirk, Christina G.Hutten, Saya, Sibel, Bancroft, Elizabeth, Vertosick, Emily, Dadaev, Tokhir, Brendler, Charles, Page, Elizabeth, Dias, Alexander, Evans, D. Gareth, Rothwell, Jeanette, Maehle, Lovise, Axcrona, Karol, Richardson, Kate, Eccles, Diana, Jensen, Thomas, Osther, Palle J., Van Asperen, Christi J., Vasen, Hans, Kiemeney, Lambertus A., Ringelberg, Janneke, Cybulski, Cezary, Wokolorczyk, Dominika, Hart, Rachel, Glover, Wayne, Lam, Jimmy, Taylor, Louise, Salinas, Monica, Feliubadaló, Lidia, Oldenburg, Rogier, Cremers, Ruben, Verhaegh, Gerald, Van Zelst-Stams, Wendy A., Oosterwijk, Jan C., Cook, Jackie, Rosario, Derek J., Buys, Saundra S., Conner, Tom, Domchek, Susan, Powers, Jacquelyn, Ausems, Margreet Gem, Teixeira, Manuel R., Maia, Sofia, Izatt, Louise, Schmutzler, Rita, Rhiem, Kerstin, Foulkes, William D., Boshari, Talia, Davidson, Rosemarie, Ruijs, Marielle, Helderman-Van Den Enden, Apollonia Tjm, Andrews, Lesley, Walker, Lisa, Snape, Katie, Henderson, Alex, Jobson, Irene, Lindeman, Geoffrey J., Liljegren, Annelie, Harris, Marion, Adank, Muriel A., Kirk, Judy, Taylor, Amy, Susman, Rachel, Chen-Shtoyerman, Rakefet, Pachter, Nicholas, Spigelman, Allan, Side, Lucy, Zgajnar, Janez, Mora, Josefina, Brewer, Carole, Gadea, Neus, Brady, Angela F., Gallagher, David, Van Os, Theo, Donaldson, Alan, Stefansdottir, Vigdis, Barwell, Julian, James, Paul A., Murphy, Declan, Friedman, Eitan, Nicolai, Nicola, Greenhalgh, Lynn, Obeid, Elias, Mikropoulos, Christos, Selkirk, Christina G.Hutten, Saya, Sibel, Bancroft, Elizabeth, Vertosick, Emily, Dadaev, Tokhir, Brendler, Charles, Page, Elizabeth, Dias, Alexander, Evans, D. Gareth, Rothwell, Jeanette, Maehle, Lovise, Axcrona, Karol, Richardson, Kate, Eccles, Diana, Jensen, Thomas, Osther, Palle J., Van Asperen, Christi J., Vasen, Hans, Kiemeney, Lambertus A., Ringelberg, Janneke, Cybulski, Cezary, Wokolorczyk, Dominika, Hart, Rachel, Glover, Wayne, Lam, Jimmy, Taylor, Louise, Salinas, Monica, Feliubadaló, Lidia, Oldenburg, Rogier, Cremers, Ruben, Verhaegh, Gerald, Van Zelst-Stams, Wendy A., Oosterwijk, Jan C., Cook, Jackie, Rosario, Derek J., Buys, Saundra S., Conner, Tom, Domchek, Susan, Powers, Jacquelyn, Ausems, Margreet Gem, Teixeira, Manuel R., Maia, Sofia, Izatt, Louise, Schmutzler, Rita, Rhiem, Kerstin, Foulkes, William D., Boshari, Talia, Davidson, Rosemarie, Ruijs, Marielle, Helderman-Van Den Enden, Apollonia Tjm, Andrews, Lesley, Walker, Lisa, Snape, Katie, Henderson, Alex, Jobson, Irene, Lindeman, Geoffrey J., Liljegren, Annelie, Harris, Marion, Adank, Muriel A., Kirk, Judy, Taylor, Amy, Susman, Rachel, Chen-Shtoyerman, Rakefet, Pachter, Nicholas, Spigelman, Allan, Side, Lucy, Zgajnar, Janez, Mora, Josefina, Brewer, Carole, Gadea, Neus, Brady, Angela F., Gallagher, David, Van Os, Theo, Donaldson, Alan, Stefansdottir, Vigdis, Barwell, Julian, James, Paul A., Murphy, Declan, Friedman, Eitan, Nicolai, Nicola, Greenhalgh, Lynn, and Obeid, Elias

Published
2018

58. Erratum: Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Author

Mikropoulos, Christos, Christina Hutten, Saya, Sibel, Bancroft, Elizabeth, Vertosick, Emily, Dadaev, Tokhir, Brendler, Charles, Page, Elizabeth, Dias, Alexander, Evans, D. Gareth, Rothwell, Jeanette, Maehle, Lovise, Axcrona, Karol, Richardson, Kate, Eccles, Diana, Jensen, Thomas, Osther, Palle J., Asperen, Christi J., Vasen, Hans, Kiemeney, Lambertus A., Ringelberg, Janneke, Cybulski, Cezary, Wokolorczyk, Dominika, Hart, Rachel, Glover, Wayne, Lam, Jimmy, Taylor, Louise, Salinas, Monica, Feliubadaló, Lidia, Oldenburg, Rogier, Cremers, Ruben, Verhaegh, Gerald, Zelst-Stams, Wendy A., Oosterwijk, Jan C., Cook, Jackie, Rosario, Derek J., Buys, Saundra S., Conner, Tom, Domchek, Susan, Powers, Jacquelyn, Ausems, Margreet Gem, Teixeira, Manuel R., Maia, Sofia, Izatt, Louise, Schmutzler, Rita, Rhiem, Kerstin, Foulkes, William D., Boshari, Talia, Davidson, Rosemarie, Ruijs, Marielle, Helderman-Van Den Enden, Apollonia Tjm, Andrews, Lesley, Walker, Lisa, Snape, Katie, Henderson, Alex, Jobson, Irene, Lindeman, Geoffrey J., Liljegren, Annelie, Harris, Marion, Adank, Muriel A., Kirk, Judy, Taylor, Amy, Susman, Rachel, Chen-Shtoyerman, Rakefet, Pachter, Nicholas, Spigelman, Allan, Side, Lucy, Zgajnar, Janez, Mora, Josefina, Brewer, Carole, Gadea, Neus, Brady, Angela F., Gallagher, David, Os, Theo, Donaldson, Alan, Stefansdottir, Vigdis, Barwell, Julian, James, Paul A., Murphy, Declan, Friedman, Eitan, Nicolai, Nicola, Greenhalgh, Lynn, Obeid, Elias, Murthy, Vedang, Copakova, Lucia, Mcgrath, John, Teo, Soo-Hwang, Strom, Sara, Kast, Karin, Leongamornlert, Daniel A., Chamberlain, Anthony, Pope, Jenny, Newlin, Anna C., Aaronson, Neil, Ardern-Jones, Audrey, Bangma, Chris, Castro, Elena, Dearnaley, David, Eyfjörð, Jórunn Erla, Falconer, Alison, Foster, Christopher S., Gronberg, Henrik, Hamdy, Freddie C., Johannsson, Oskar, Khoo, Vincent, Lubinski, Jan, Grindedal, Eli Marie, Mckinley, Joanne, Shackleton, Kylie, Mitra, Anita V., Moynihan, Clare, Rennert, Gad, Suri, Mohnish, Tricker, Karen, Moss, Sue, Kote-Jarai, Zsofia, Vickers, Andrew, Lilja, Hans, Helfand, Brian T., Eeles, Rosalind A., Læknadeild (HÍ), Faculty of Medicine (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, University of Iceland, Epidemiology and Data Science, CCA - Cancer Treatment and quality of life, VU University medical center, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Clinical Genetics, Urology, Human Genetics, and CCA - Cancer Treatment and Quality of Life

Subjects
Male, Oncology, Cancer Research, IMPACT, Prostate Specific Antigen Velocity, 030232 urology & nephrology, Genetics & Genomics, urologic and male genital diseases, PSA velocity, INCREASE, WINDOW, predictive model, 0302 clinical medicine, BRCA2 MUTATION CARRIERS, Early Detection of Cancer, RISK, IMPACT study collaborators, BRCA1 Protein, DEATH, Middle Aged, prostate cancer, 3. Good health, Prostate cancer screening, 030220 oncology & carcinogenesis, Kallikreins, Corrigendum, Erfðarannsóknir, Life Sciences & Biomedicine, Adult, medicine.medical_specialty, Blöðruhálskirtilskrabbamein, 1117 Public Health and Health Services, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Journal Article, medicine, Genetic predisposition, Humans, Genetic Predisposition to Disease, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Germ-Line Mutation, Aged, Krabbamein, BRCA2 Protein, Science & Technology, business.industry, Prostatic Neoplasms, Cancer, Prostate-Specific Antigen, BRCA1, medicine.disease, BRCA2, Logistic Models, CURABILITY, Neoplasm Grading, business, genetic predisposition
Abstract

Background: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutations. This analysis evaluates the utility of PSA and PSAV for identifying PrCa and high-grade disease in this cohort. Methods: PSAV was calculated using logistic regression to determine if PSA or PSAV predicted the result of prostate biopsy (PB) in men with elevated PSA values. Cox regression was used to determine whether PSA or PSAV predicted PSA elevation in men with low PSAs. Interaction terms were included in the models to determine whether BRCA status influenced the predictiveness of PSA or PSAV. Results: 1634 participants had 3 PSA readings of whom 174 underwent PB and 45 PrCas diagnosed. In men with PSA >3.0 ng ml−l, PSAV was not significantly associated with presence of cancer or high-grade disease. PSAV did not add to PSA for predicting time to an elevated PSA. When comparing BRCA1/2 carriers to non-carriers, we found a significant interaction between BRCA status and last PSA before biopsy (P=0.031) and BRCA2 status and PSAV (P=0.024). However, PSAV was not predictive of biopsy outcome in BRCA2 carriers. Conclusions: PSA is more strongly predictive of PrCa in BRCA carriers than non-carriers. We did not find evidence that PSAV aids decision-making for BRCA carriers over absolute PSA value alone., This research is coordinated by the Institute of Cancer Research, London, UK and is supported by grants from Cancer Research UK (Grant references (C5047/A21332, C5047/A13232 and C5047/A17528) and The Ronald and Rita McAulay Foundation. Mr and Mrs Jack Baker for the study in NorthShore University HealthSystem, Evanston, Illinois and Myriad Genetics Laboratory, Salt Lake City, Utah, for providing research BRCA testing rates for NorthShore University HealthSystem participants. We acknowledge funding from the NIHR to the Biomedical Research Center at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, at Central Manchester Foundation Trust and the Oxford Biomedical Research Centre Program. We acknowledge that in Australia, this project was co-funded by Cancer Council Tasmania and Cancer Australia, grant number 1006349 (2011–2013), Prostate Cancer Foundation of Australia, grant number PCFA PRO4 (2008) and Cancer Councils of Victoria and South Australia, grant number 400048 (2006–2008), The Victorian Cancer Agency Clinical Trial Capacity CTCB08_14, Cancer Australia & Prostate Cancer Foundation of Australia (2014–2016) grant number 1059423, and Translational grants EOI09_50. The Association of International Cancer Research funded data collection in The Netherlands (AICR 10–0596). We acknowledge funding from the Basser Center for BRCA (to S Domchek). We acknowledge funding from the National Cancer Institute [P30-CA008748], the Sidney Kimmel Center for Prostate and Urologic Cancers, and David H. Koch through the Prostate Cancer Foundation, the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK, Swedish Cancer Society (Cancerfonden project no. 11–0624), and the Swedish Research Council (VR-MH project no. 2016–02974). We acknowledge funding from the Slovenian Research Agency, Research programme P3–0352. Elena Castro acknolwedges funding from a Juan de la Cierva’ fellowship from MINIECO (grant reference IJCI- 2014–19129). We acknowledge the support of the Asociación Española Contra el Cáncer (AECC), the Instituto de Salud Carlos III (organismo adscrito al Ministerio de Economía y Competitividad) and ‘Fondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa’ (PI10/01422, PI13/00285, PIE13/00022, PI16/00563 and CIBERONC) and the Institut Català de la Salut and Autonomous Government of Catalonia (2009SGR290, 2014SGR338 and PERIS Project MedPerCan).

Published
2018

59. Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic Evaluation

Author

Giri, Veda N., primary, Obeid, Elias, additional, Gross, Laura, additional, Bealin, Lisa, additional, Hyatt, Colette, additional, Hegarty, Sarah E., additional, Montgomery, Susan, additional, Forman, Andrea, additional, Bingler, Ruth, additional, Kelly, William K., additional, Dicker, Adam P., additional, Winheld, Stephanie, additional, Trabulsi, Edouard J., additional, Chen, David Y.T., additional, Lallas, Costas D., additional, Allen, Brian A., additional, Daly, Mary B., additional, and Gomella, Leonard G., additional

Published
2017
Full Text
View/download PDF

60. Are we still adjusting to multigene panel testing? An NCI-designated cancer center's 2-year experience.

Author

Ramamurthy, Chethan, primary, Hitrik, Mark A., additional, DeMora, Lyudmila, additional, Forman, Andrea, additional, Rainey, Kim, additional, Savage, Michelle, additional, Montgomery, Susan, additional, Masny, Agnes, additional, Schwartz, Sharon, additional, Hall, Michael J., additional, Daly, Mary Beryl, additional, and Obeid, Elias, additional

Published
2017
Full Text
View/download PDF

64. Effect of exogenous interferon-gamma (IFN-gamma) on peripheral blood immune markers as part of a phase I clinical trial of combined IFN-gamma with nivolumab (Nivo) in patients (pts) with select solid tumors.

Author

Zibelman, Matthew R., primary, Macfarlane, Alexander, additional, Alpaugh, R. Katherine, additional, Dulaimi, Essel, additional, Costello, Kim, additional, O'Neill, John, additional, Borghaei, Hossein, additional, Denlinger, Crystal Shereen, additional, Geynisman, Daniel M., additional, Dotan, Efrat, additional, Jain, Angela, additional, Martin, Lainie P., additional, Obeid, Elias, additional, Nieves, Jeffery A., additional, Crouteau, David, additional, Grahn, Amy Y., additional, Campbell, Kerry, additional, and Plimack, Elizabeth R., additional

Published
2017
Full Text
View/download PDF

67. Nipple Discharge After Nipple-Sparing Mastectomy With and Without Associated Pregnancy.

Author

Mateo, Alina M., Mazor, Anna M., DeMora, Lyudmila, Sigurdson, Elin R., Handorf, Elizabeth A., Daly, John M., Aggon, Allison A., Obeid, Elias, Hayes, Shelly B., Bleicher, Richard J., Tang, Rong, Kelly, Bridget N, Smith, Barbara L, Lanahan, Conor R, Brown, Carson L, Gadd, Michele A, Hughes, Kevin S, Oseni, Tawakalitu O, McGugin, Caroline, and Specht, Michelle C

Published
2019
Full Text
View/download PDF

68. Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style.

Author

Roussi, Pagona, Miller, Suzanne M., Wen, Kuang-Yi, Tagai, Erin K., Scarpato, John, Roy, Gem, Obeid, Elias, Giri, Veda N., and Gross, Laura

Subjects
PROSTATE tumors, PROSTATE tumors treatment, PSYCHOLOGICAL adaptation, AFFECT (Psychology), COGNITION, COUNSELING, HEALTH education, MEDICAL appointments, MEN'S health, PSYCHOLOGY of men, RACE, RANDOMIZED controlled trials, HUMAN services programs, HEALTH literacy, EVALUATION of human services programs, DIAGNOSIS, TUMOR risk factors
Abstract

Despite conflicting guidelines, a significant subset of high-risk men decide to undergo routine prostate cancer screening. Yet, there is a scarcity of available programs, and no studies evaluating interventions to support men in dealing with the psychosocial impact of screening. In this study, one of the first to explore the responses of high-risk men enrolling in a Prostate Cancer Risk Assessment Program (N = 128), patients underwent a prostate cancer risk counseling visit immediately followed by either a cognitive–affective preparation session designed to help them process the information they received or a general health education session. All men in this self-selected sample chose to participate in prostate cancer screening. Men were assessed 3 weeks and 6 months post-counseling. The impact of the enhanced counseling condition on knowledge, perceived risk, expectancies, and intrusive ideation was a function of racial and coping style group. Implications for tailored interventions to maximize preparedness for risk and screening counseling are discussed. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

70. A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer

Author

Nanda, Rita, primary, Stringer-Reasor, Erica M., additional, Saha, Poornima, additional, Kocherginsky, Masha, additional, Gibson, Jean, additional, Libao, Bernadette, additional, Hoffman, Philip C., additional, Obeid, Elias, additional, Merkel, Douglas E., additional, Khramtsova, Galina, additional, Skor, Maxwell, additional, Krausz, Thomas, additional, Cohen, Ronald N., additional, Ratain, Mark J., additional, Fleming, Gini F., additional, and Conzen, Suzanne D., additional

Published
2016
Full Text
View/download PDF

74. Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project

Author

Fleisher, Linda, primary, Davis, Stacy N., additional, Gross, Laura, additional, Bagden, Loretta, additional, Zakrzewski, Debra, additional, González, Evelyn, additional, Kandadai, Venk, additional, Rusten, Cheryl, additional, Baskett, Jerilyn, additional, Obeid, Elias, additional, and Giri, Veda N., additional

Published
2015
Full Text
View/download PDF

77. Breast cancer surveillance in high-risk women with magnetic resonance imaging every 6 months.

Author

Guindalini, Rodrigo Santa Cruz, primary, Huang, Yi-Ching, additional, Obeid, Elias, additional, Patrick-Miller, Linda, additional, Bradbury, Angela R., additional, Verp, Marion S., additional, Hong, Susan, additional, Wroblewski, Kristen, additional, Abe, Hiroyuki, additional, Karczmar, Greg S., additional, Newstead, Gillian, additional, and Olopade, Olufunmilayo I., additional

Published
2013
Full Text
View/download PDF

79. Recall rate in a semi-annual breast surveillance program for high-risk women.

Author

Abe, Hiroyuki, primary, Guindalini, Rodrigo Santa Cruz, additional, Obeid, Elias, additional, Patrick-Miller, Linda J., additional, Bradbury, Angela R., additional, Verp, Marion S., additional, Hong, Susan, additional, Wroblewski, Kristen, additional, Karczmar, Greg S., additional, Newstead, Gillian, additional, and Olopade, Olufunmilayo I., additional

Published
2013
Full Text
View/download PDF

83. Early onset HER2-positive breast cancer is associated with germlineTP53mutations

Author

Melhem-Bertrandt, Amal, primary, Bojadzieva, Jasmina, additional, Ready, Kaylene J., additional, Obeid, Elias, additional, Liu, Diane D., additional, Gutierrez-Barrera, Angelica M., additional, Litton, Jennifer K., additional, Olopade, Olufunmilayo I., additional, Hortobagyi, Gabriel N., additional, Strong, Louise C., additional, and Arun, Banu K., additional

Published
2011
Full Text
View/download PDF

84. Mutations in context: implications of BRCA testing in diverse populations.

Author

Felix, Gabriela E. S., Zheng, Yonglan, and Olopade, Olufunmilayo I.

Abstract

Cancer is a common non-communicable disease worldwide, although it exhibits differential population trends in incidence and mortality rates. The differences relate to population structure, environmental risk factors as well as health system organization. This article discusses the potential impact of genetic testing on population health, focusing in particular on the mutational spectrum of breast cancer susceptibility genes in diverse populations. We identify the need for improved access to, and increased investment in, comprehensive cancer risk assessment and genetic testing as well as cancer control measures that take into account lifestyle, environmental, and social factors in understudied minority groups. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

85. Ten Years in Captivity in the Madhi's Camp

Author

Father Joseph Ohrwalder and Father Joseph Ohrwalder

Abstract

Father Joseph Ohrwalder was born on March 6, 1856 at Lana in the South Tyrol was a Roman Catholic priest, who was taken captive by the Mahdists in Sudan while working as a missionary there. He spent ten years in captivity but eventually escaped. He died on August 8th, 1913 at Omdurman in the Sudan. The German manuscript of his travails was rendered into English by Francis Reginald Wingate. General Sir Francis Reginald Wingate, 1st Baronet GCB GCVO GBE KCMG DSO TD was born at Port Glasgow, Renfrewshire on June 25th 1861. Wingate entered the Royal Military Academy, Woolwich, and was commissioned as a Lieutenant in the Royal Artillery on 27 July 1880. He served in India and Aden from March 1881 to 1883. He then joined the 4th Battalion of the Egyptian Army with the brevet rank of Major. In the Gordon Relief Expedition of 1884–1885 he was ADC and military secretary to Sir Evelyn Wood. In 1883 he received the Order of Osmanieh 4th Class from the Khedive and in June 1885 he was Mentioned in Despatches for service in operations in the Suakin and Upper Nile regions. After holding an appointment in England for a brief period as ADC to Wood, who was now General Officer Commanding Eastern District, he rejoined the Egyptian Army in 1886 as assistant military secretary to Sir Francis Grenfell. In 1887 he received the Order of the Medjidieh 4th Class and took part in the operations on the Sudan frontier in 1889, including the engagement at Toski — for which he was awarded the Distinguished Service Order (DSO) — and in the further operations in 1891, being present at the capture of Tokar. His principal work was in the intelligence branch, of which he became assistant adjutant-general in 1888 and director in 1892. A master of Arabic, his knowledge of the country, the examination of prisoners, refugees and others from the Sudan, and the study of documents captured from the Dervishes enabled him to publish in 1891 Mahdiism and the Egyptian Sudan, an authoritative account of the rise of the Muhammad Ahmad and of subsequent events in the Sudan up to that date. In 1891 he was promoted to the 3rd Class of the Order of the Medjidieh. By 1894 he was governor of Suakin and appointed Companion of the Order of the Bath in the 1895 Queen's Birthday Honours. Wingate was promoted to Brevet Lieutenant-Colonel on 18 November 1896 and after the Battle of Atbara in 1898 he interrogated the defeated dervish commander Emir Mahmoud. Largely through his assistance, Father Ohrwalder and two nuns escaped from Omdurman in 1891. Wingate also made the arrangements which led to the escape of Slatin Pasha in 1895. He translated into English Father Ohrwalder's narrative (Ten Years in the Mahdi's Camp, 1892) and Slatin's book (Fire and Sword in the Sudan, 1896).

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results